Augusta (Georgia) [US], April 28 (ANI): According to the Medical College of Georgia at Augusta University, about one-fifth of the often fatal head and neck cancers contain gene mutations in pathways important for normal cell proliferation, and scientists say these mutations that cause cancer
Washington [US], March 20 (ANI): Do you know malaria drugs work against some cancers? According to a new study, the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisp
Washington [US], March 15 (ANI): A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisplatin in animal models.
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Washington [US], May 27 (ANI): Up to half of the patients with head and neck squamous cell carcinoma will experience tumour recurrence or new tumours- tumours that often spread and are difficult to treat.
Brasilia [Brazil], May 26 (ANI): A research group at Sao Paulo State University (UNESP) has analyzed how Candida albicans fungi and Staphylococcus aureus bacteria influence gene expression and tumour cell survival.
Washington [US], May 2 (ANI): A multi-institutional study, drove by the Proceedings of the National Academy of Sciences journal, distinguished both the hereditary abnormalities that drive pre-cancer cells that lead to an intrusive kind of head and neck cancer and patients who are liable to r
Washington [US], April 27 (ANI): A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
Los Angeles [US], March 28 (ANI): Researchers from the UCLA School of Dentistry, during a recent study, were successful in significantly slowing down the growth and spread of tumors in mice by targeting an enzyme that plays a key role in head and neck cancer cells. This also enhanced the eff
Los Angeles [US], March 24 (ANI): Researchers from the UCLA School of Dentistry were able to significantly slow the growth and spread of tumors in mice by targeting an enzyme that plays a key role in head and neck cancer cells. They were also able to enhance the effectiveness of immunotherap
Washington [US], January 23 (ANI): Researchers at the University of Cincinnati have tested a new combination therapy in animal models to see if they could find a way to make an already effective treatment even better.